Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey

BACKGROUND: Durvalumab as maintenance treatment after platinum-based concurrent chemoradiotherapy (cCRT) has become the standard of care in inoperable stage III non-small cell lung cancer (NSCLC). In this nationwide survey, we solicited members of the German Radiation Oncology Society to review the...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Transl Lung Cancer Res
Auteurs principaux: Käsmann, Lukas, Eze, Chukwuka, Taugner, Julian, Roengvoraphoj, Olarn, Belka, Claus, Manapov, Farkhad
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225149/
https://ncbi.nlm.nih.gov/pubmed/32420068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2020.03.25
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires